Eternal Tumor Virus (ETV): A new development in the treatment of benign and malignant tumors (cancer) by Habiba El Sayed, Scientific Research Journal (Scirj), Volume VIII, Issue XI, November 2020 Edition

Scirj Volume VIII, Issue XI, November 2020 Edition
ISSN: 2201-2796

Eternal Tumor Virus (ETV): A new development in the treatment of benign and malignant tumors (cancer)

Habiba El Sayed

Abstract: The relationship between cancer regression and viruses has long been theorized about, with case reports of the observed regression in cervical cancer, Burkitt lymphoma and Hodgkin lymphoma, following immunization or infection with an unrelated virus at the beginning of the twentieth century. Efforts to treat cancer through immunization or virotherapy (deliberate infection with a virus) began in the mid-twentieth century. Since the technology to create a custom virus did not exist, all early efforts focused on creating naturally occurring tumor-resolving viruses. During the 1960s, promising research was involving the use of poliovirus, adenovirus, Coxsackie virus, enterovirus Riga virus and others. Early complications were occasional cases of uncontrolled infection, resulting in significant morbidity and mortality rates; The very frequent development of the immune response, while it is not harmful to the patient, led to the destruction of the virus, and thus prevented it from destroying the tumor. Therefore, my study followed up and searched for the best types of viruses that could not affect in any way on the human being because there is a fast and guaranteed solution to treat various tumors. Its forms are either a benign or malignant tumor (cancer).

Reference this Paper: Eternal Tumor Virus (ETV): A new development in the treatment of benign and malignant tumors (cancer) by Habiba El Sayed published at: "Scientific Research Journal (Scirj), Volume VIII, Issue XI, November 2020 Edition, Page 1-7 ".

Search Terms: Brain , Viruses, Tumors, Genetic testing

[Read Research Paper] [Full Screen]